Quick Research
Filters Clear All
Any Time
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 25,274 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC (2024-07-14)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: THP-1 Cell Complete Medium -
A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling (2024-08-07)
-
MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1α/NDUFA4L2 axis (2024-08-17)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: NCI-H226 [H226] Cells Line, SK-MES-1 Cells Line -
Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer (2024-08-20)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: RPMI-1640, without phenol red Medium -
USP33 facilitates the ovarian cancer progression via deubiquitinating and stabilizing CBX2 (2024-09-10)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: NIH:OVCAR-3 [OVCAR3] Cells Line, ES-2 Cells Line, Hey Cells Line, Caov-3 Cells Line, A2780 Cells Line, SW626 Cells Line, SK-OV-3 Cells Line, 293T [HEK-293T] Cells Line -
Single-cell RNA-sequencing reveals a unique landscape of the tumor microenvironment in obesity-associated breast cancer (2024-09-16)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: Penicillin-Streptomycin Solution, 100 × -
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCC (2024-10-23)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: HUV-EC-C [HUVEC] Cells Line, A-498 Cells Line, Ham's F-12K Medium -
RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1 (2024-11-11)
-
A novel micropeptide miPEP205 suppresses the growth and metastasis of TNBC (2024-12-02)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: BT-549 Cells Line, MDA-MB-231 Cells Line -
TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma (2024-12-10)
Journal: ONCOGENE (2024) IF: 6.9Products Cited: PC-9 Cells Line, HCC827 Cells Line
